Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OCTREOTIDE ACETATE
- Dexamethasone/Pancreatic Clamp P&F
- Pancreatic Clamp in NAFLD
- A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
- A Feasibility Study of Octreotide Infusion During Liver Transplant.
- Octreotide LAR in the Induction of Immunologic Response in NENs Patients
- Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
- A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers
- Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
- Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide
- Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects
- A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)
- Ghrelin Suppression by Octreotide in Prader-Willi
- Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
- Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients
- Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
- Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg, Imported And Distributed By The Laboratory Chemical Pharmaceutical Bergamo Ltda., Compared To Product Sandostatin LAR ® (Octreotide Acetate LAR) 30 MG Manufactured By Novartis Biosciences S
- Open Label Study of Octreotide Implant in Patients With Acromegaly
- A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
- Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
- Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
- Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
- Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
- Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
- AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
- Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
- Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
- Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
- Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
- Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
- Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
- Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
- Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
- Octreotide in Treating Patients With Cancer-Related Malignant Ascites
- Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients
- Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
- Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
- Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
- Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
- Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
- Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
- Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
- Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
- Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
- Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
- Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
Clinical trials list
click for details